Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Quantum BioPharma Ltd > Back To The Pump
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(287)
•••
Comment by Renofundon Nov 13, 2021 2:12pm
51 Views
Post# 34123456

RE:RE:RE:Back To The Pump

RE:RE:RE:Back To The Pump
Renofund wrote:
DavidRosenberg wrote:
Mil_Man54 wrote: A new day and same PR BS pumping......nothing new....nothing of value to those doing their DD....just hype...hype....hype with zero substance.




What do you mean no substance

Pfizer does scouting at UHN Network do you agree?  Since there was a buyout of trillium therapeutics for 2.2 Billion Dollars  Pfizer to Acquire Trillium Therapeutics Inc. | Pfizer

Lucid Psychecuticals also will be operating out of UHN Network as well aren't they? 


 

 

OK, so present the full case then.  Classic promoter tactic.  "Look what happened here, we can equate it to us".  Perhaps, but perhaps not. You had the same case when they were in pot (look at the other guys) and COVID.  So, how many companies have worked out of UNH, and then how many have been bought out?  You are only presenting a numerator, what's the denominator?  Fun with numbers, eh?  Present the whole story.  What % of names have been successful coming out of UNH? What percentage of companies have been bought out?  


david likes to push posts to bottom of page, so let's get this one back to the top and watch him post random youtube vids instead of providing complete information 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities